Articles

Nearly half of U.S. adults are struggling to cover the cost of prescription drugs and doctor visits, new research shows, marking a new low for healthcare affordability.

Johnson & Johnson’s stock seesawed into the red in early trading Wednesday, after the drugmaker beat second-quarter profit expectations but lowered its full-year outlook.

The U.S. stock market on average has done better when Congress is not in session.

‘Probably by the end of this year or next year, the bear market will have resumed in the U.S.,’ Quantum Fund co-founder says.

Company to raise up to $3.85 billion at a valuation of up to $19.2 billion

A leading Federal Reserve official says he still needs a little more convincing before endorsing an interest-rate cut, a comment that all but rules out a reduction later this month.

“Our kids and grandkids won’t get our Social Security if we pass away at a younger age.”

The star investor seems to have correctly made a giant call.

Mortgage applications rose 3.9% in the last week, the Mortgage Bankers Association said.

Oppenheimer’s Chris Kotowski cuts rating on investment bank to neutral from buy

‘Strategic portfolio review concluded there are limited synergies between Supreme and VF, making a sale a natural next step,’ says CEO

The Lebanese born banker, who first joined HSBC in 2005, had been seen as the natural successor to Quinn who announced he would be stepping down in April